SLC5A2 and osteosarcoma: Consistently, the expression of STING in osteosarcoma cells was also upregulated after treatment with other SGLT2 inhibitors, including Sotagliflozin, Dapagliflozin, and Tofogliflozin (Fig. 4h, i and Supplementary Fig. 3h).